Traders Buy Large Volume of Call Options on Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the target of some unusual options trading activity on Tuesday. Stock investors purchased 52,865 call options on the company. This represents an increase of approximately 172% compared to the average volume of 19,422 call options.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. Nuveen LLC purchased a new stake in Teladoc Health in the 1st quarter worth approximately $11,789,000. Vanguard Group Inc. lifted its position in Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock worth $157,229,000 after buying an additional 1,289,183 shares in the last quarter. Bridgeway Capital Management LLC purchased a new stake in Teladoc Health in the 2nd quarter worth approximately $8,729,000. Trexquant Investment LP lifted its position in Teladoc Health by 198.9% in the 1st quarter. Trexquant Investment LP now owns 907,859 shares of the health services provider’s stock worth $7,227,000 after buying an additional 604,116 shares in the last quarter. Finally, Empowered Funds LLC purchased a new stake in Teladoc Health in the 2nd quarter worth approximately $5,040,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Up 2.4%

TDOC stock opened at $8.39 on Wednesday. Teladoc Health has a 12 month low of $6.35 and a 12 month high of $15.21. The firm has a market cap of $1.48 billion, a PE ratio of -7.05 and a beta of 1.84. The firm has a 50 day simple moving average of $7.66 and a 200 day simple moving average of $7.62. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC) last released its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business’s quarterly revenue was down 1.6% on a year-over-year basis. During the same period in the prior year, the business earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Equities research analysts forecast that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of recent research reports. Mizuho initiated coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a “neutral” rating and a $10.00 price objective for the company. Evercore ISI boosted their price objective on shares of Teladoc Health from $7.00 to $8.00 and gave the company an “in-line” rating in a research report on Wednesday, July 9th. Truist Financial lowered their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Tuesday, May 27th. Finally, Bank of America decreased their target price on shares of Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a research report on Wednesday, May 28th. Six analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $9.80.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.